These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17709402)

  • 1. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation.
    Van Lint P; Libert C
    J Leukoc Biol; 2007 Dec; 82(6):1375-81. PubMed ID: 17709402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
    van Hinsbergh VW; Koolwijk P
    Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic processing of chemokines: implications in physiological and pathological conditions.
    Wolf M; Albrecht S; Märki C
    Int J Biochem Cell Biol; 2008; 40(6-7):1185-98. PubMed ID: 18243768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracellular matrix metalloproteinases--perspectives of their use in medicine].
    Kotulska-Wolwender K; Larysz-Brysz M; Fus Z; Korczyńska I; Górka D; Lewin-Kowalik J
    Wiad Lek; 2002; 55(7-8):463-71. PubMed ID: 12428575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.
    Tomlinson ML; Garcia-Morales C; Abu-Elmagd M; Wheeler GN
    Mech Dev; 2008; 125(11-12):1059-70. PubMed ID: 18684398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
    Cauwe B; Opdenakker G
    Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis.
    Loftus JP; Johnson PJ; Belknap JK; Pettigrew A; Black SJ
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):221-30. PubMed ID: 19101039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinases and Leukocyte Activation.
    Smigiel KS; Parks WC
    Prog Mol Biol Transl Sci; 2017; 147():167-195. PubMed ID: 28413028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.
    Overall CM; McQuibban GA; Clark-Lewis I
    Biol Chem; 2002; 383(7-8):1059-66. PubMed ID: 12437088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases in the pathogenesis of viral heart disease.
    Marchant D; McManus BM
    Trends Cardiovasc Med; 2009 Jan; 19(1):21-6. PubMed ID: 19467450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round.
    De Buck M; Gouwy M; Struyf S; Opdenakker G; Van Damme J
    Immunol Lett; 2019 Jan; 205():1-8. PubMed ID: 29870759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and cellular motility in development and disease.
    VanSaun MN; Matrisian LM
    Birth Defects Res C Embryo Today; 2006 Mar; 78(1):69-79. PubMed ID: 16622849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation and matrix metalloproteinases in viral myocarditis.
    Westermann D; Savvatis K; Schultheiss HP; Tschöpe C
    J Mol Cell Cardiol; 2010 Mar; 48(3):468-73. PubMed ID: 19729021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural post-translational modifications of chemokines.
    Proost P; Struyf S; Van Damme J
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):997-1001. PubMed ID: 17073736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
    Mortier A; Gouwy M; Van Damme J; Proost P
    Exp Cell Res; 2011 Mar; 317(5):642-54. PubMed ID: 21146523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalization and unconventional functions of cellular MMPs in cancer.
    Strongin AY
    Cancer Metastasis Rev; 2006 Mar; 25(1):87-98. PubMed ID: 16680575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases as modulators of inflammation.
    Manicone AM; McGuire JK
    Semin Cell Dev Biol; 2008 Feb; 19(1):34-41. PubMed ID: 17707664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].
    Hrabec E; Naduk J; Strek M; Hrabec Z
    Postepy Biochem; 2007; 53(1):37-45. PubMed ID: 17718386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding effects of matrix protease and matrix organization on directional persistence and translational speed in three-dimensional cell migration.
    Zaman MH; Matsudaira P; Lauffenburger DA
    Ann Biomed Eng; 2007 Jan; 35(1):91-100. PubMed ID: 17080315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.